The Oncology Institute Names Kristin England as Chief Administrative Officer
The Oncology Institute (NASDAQ: TOI), a leading value-based oncology group in the United States, has appointed Kristin England as its new Chief Administrative Officer (CAO), effective July 7, 2025. In this newly created position, England will be responsible for overseeing Enterprise Central Business Operations and Technology Strategy across TOI's national operations.
England joins TOI with over 20 years of healthcare management experience, previously serving as a senior executive at McKesson's US Oncology Network, where she specialized in revenue cycle optimization and practice management systems improvement. CEO Daniel Virnich emphasized that England's appointment comes at a crucial time as TOI focuses on scaling its MSO model and strengthening its value-based care approach.
L'Istituto di Oncologia (NASDAQ: TOI), un gruppo oncologico statunitense leader nel modello basato sul valore, ha nominato Kristin England come nuova Chief Administrative Officer (CAO), con decorrenza dal 7 luglio 2025. In questo ruolo di nuova creazione, England sarà responsabile della supervisione delle Operazioni Centrali Aziendali e della Strategia Tecnologica su scala nazionale per TOI.
England entra in TOI con oltre 20 anni di esperienza nella gestione sanitaria, avendo ricoperto in precedenza ruoli dirigenziali senior presso la rete US Oncology di McKesson, specializzandosi nell'ottimizzazione del ciclo di ricavi e nel miglioramento dei sistemi di gestione delle pratiche. Il CEO Daniel Virnich ha sottolineato che la nomina di England avviene in un momento cruciale, mentre TOI si concentra sull'espansione del modello MSO e sul rafforzamento del suo approccio alla cura basata sul valore.
El Instituto de Oncología (NASDAQ: TOI), un grupo líder de oncología basado en el valor en Estados Unidos, ha nombrado a Kristin England como su nueva Directora Administrativa (CAO), con efecto a partir del 7 de julio de 2025. En este puesto recientemente creado, England será responsable de supervisar las Operaciones Centrales Empresariales y la Estrategia Tecnológica en las operaciones nacionales de TOI.
England se une a TOI con más de 20 años de experiencia en gestión sanitaria, habiendo desempeñado anteriormente cargos ejecutivos senior en la Red de Oncología de EE. UU. de McKesson, donde se especializó en la optimización del ciclo de ingresos y la mejora de los sistemas de gestión de prácticas. El CEO Daniel Virnich destacó que el nombramiento de England llega en un momento crucial, mientras TOI se enfoca en escalar su modelo MSO y fortalecer su enfoque de atención basada en el valor.
종양학 연구소(NASDAQ: TOI)는 미국 내 가치 중심 종양학 그룹의 선두주자로서, 크리스틴 잉글랜드를 2025년 7월 7일부로 새로운 최고행정책임자(CAO)로 임명했습니다. 새로 신설된 이 직책에서 잉글랜드는 TOI의 전국 운영 전반에 걸친 기업 중앙 비즈니스 운영 및 기술 전략을 총괄하게 됩니다.
잉글랜드는 20년 이상의 의료 관리 경험을 바탕으로 TOI에 합류했으며, 이전에는 맥케슨의 미국 종양학 네트워크에서 고위 임원으로 근무하며 수익 주기 최적화와 진료 관리 시스템 개선에 전문성을 발휘했습니다. CEO 다니엘 버니히는 잉글랜드의 임명이 TOI가 MSO 모델 확장과 가치 기반 치료 접근 강화에 집중하는 중요한 시기에 이루어졌다고 강조했습니다.
L'Institut d'Oncologie (NASDAQ : TOI), un groupe oncologique de premier plan axé sur la valeur aux États-Unis, a nommé Kristin England au poste de Directrice Administrative (CAO), à compter du 7 juillet 2025. Dans ce poste nouvellement créé, England sera responsable de la supervision des opérations centrales de l'entreprise et de la stratégie technologique à l'échelle nationale de TOI.
England rejoint TOI avec plus de 20 ans d'expérience en gestion des soins de santé, ayant précédemment occupé un poste de cadre supérieur au sein du réseau US Oncology de McKesson, où elle s'est spécialisée dans l'optimisation du cycle des revenus et l'amélioration des systèmes de gestion des pratiques. Le PDG Daniel Virnich a souligné que la nomination d'England intervient à un moment crucial, alors que TOI se concentre sur l'expansion de son modèle MSO et le renforcement de son approche des soins basés sur la valeur.
Das Onkologie-Institut (NASDAQ: TOI), eine führende wertorientierte Onkologiegruppe in den Vereinigten Staaten, hat Kristin England als neue Chief Administrative Officer (CAO) mit Wirkung zum 7. Juli 2025 ernannt. In dieser neu geschaffenen Position wird England die übergreifende Verantwortung für die zentralen Geschäftsabläufe und die Technologie-Strategie bei TOI's landesweiten Aktivitäten übernehmen.
England bringt über 20 Jahre Erfahrung im Gesundheitsmanagement mit und war zuvor als leitende Führungskraft im US Oncology Network von McKesson tätig, wo sie sich auf die Optimierung des Umsatzzyklus und die Verbesserung von Praxismanagementsystemen spezialisiert hat. CEO Daniel Virnich betonte, dass Englands Ernennung zu einem entscheidenden Zeitpunkt erfolgt, da TOI die Skalierung seines MSO-Modells und die Stärkung seines wertorientierten Versorgungsansatzes vorantreibt.
- Appointment of experienced healthcare executive with over 20 years of leadership experience
- Strategic hire to support national expansion and operational efficiency
- Strengthening of senior management team with expertise in revenue cycle optimization
- None.
CERRITOS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Kristin England has joined the organization as Chief Administrative Officer (CAO), effective July 7, 2025. In this newly established role, England will oversee Enterprise Central Business Operations and Technology Strategy and Enablement across TOI’s expanding national footprint.
England brings over two decades of leadership experience in healthcare management and operations, most recently serving as a senior executive within McKesson’s US Oncology Network. There, she led high-performing teams focused on optimizing revenue cycle performance and streamlining practice management systems to drive operational efficiency and service delivery.
“We’re thrilled to welcome Kristin to our senior leadership team at such a pivotal time for TOI,” said Daniel Virnich, CEO of The Oncology Institute. “Her track record of driving operational excellence and aligning systems for sustainable growth and efficiency will be instrumental as we scale our MSO model and deepen our commitment to value-based care.”
“It is a privilege to join The Oncology Institute at such a transformative time. I look forward to advancing our strategic priorities and supporting TOI’s continued growth through operational excellence and disciplined execution,” said England.
About The Oncology Institute
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients, including access to clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better.
For more information, visit www.theoncologyinstitute.com
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
FAQ
Who is the new Chief Administrative Officer (CAO) of The Oncology Institute (NASDAQ: TOI)?
What is Kristin England's role as CAO at The Oncology Institute (TOI)?
What is Kristin England's previous experience before joining TOI?
Why did The Oncology Institute create the CAO position?
